BioSpace News Archive

Business

Lendeavor, Inc. Announces Addition of Jason Schneller

Lendeavor, Inc., a technology-enabled lender to healthcare practices, today announced the hiring of Jason Schneller, formerly of Wells Fargo Practice Finance, as Lendeavor’s head of business development in Southern California.

August 31, 2018
·
1 min read
FDA

Aquestive Therapeutics Announces Tentative FDA Approval for Sympazan™ (clobazam) Oral Film

Sympazan is an oral soluble film formulation of clobazam, a benzodiazepine indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients 2 years of age or older

August 31, 2018
·
4 min read
Bio NC

New Best Practices, LLC Study Examines Real World Evidence Trends and Vendor Selection in Pharmaceutical Industry

Recognizing the increased complexity in evidence demands for pharmaceutical products after launch, pharmaceutical companies are boosting their internal Real World Evidence (RWE) capabilities.

August 31, 2018
·
2 min read
Business

Teamsters, Coalition Of Unions Reach Tentative Agreement With American Red Cross

The Teamsters, as part of a multi-union coalition, has reached a tentative agreement on the national addendum with American Red Cross.

August 31, 2018
·
1 min read
Biotech Bay

The First-Ever CrossFit Sanctioned Event Announced

Dubai CrossFit Championship is first officially sanctioned event -- part of recently announced changes to CrossFit Games

August 31, 2018
·
1 min read
Policy

Regional Health Properties Announces Notice of Noncompliance with NYSE American Listing Standards on August 28, 2018

Regional Health Properties, Inc. today announced that, on August 28, 2018, that the Company received a deficiency letter (the “Letter”) from NYSE American LLC

August 31, 2018
·
5 min read
FDA

Bayer Receives FDA Approval for Jivi®, New Hemophilia A Treatment With Step-Wise Prophylaxis Dosing

Jivi’s extended half-life allows for twice-weekly initial dosing and may be adjusted to every five days and further individually adjusted to less or more frequent dosing(1)

August 31, 2018
·
8 min read
Business

$50 million awarded by CPRIT to MD Anderson and its projects

The University of Texas MD Anderson Cancer Center today was awarded $30 million to support research, core facilities, recruitment and prevention efforts from the Cancer Prevention and Research Institute of Texas (CPRIT).

August 31, 2018
·
3 min read
Drug Development

Kodiak Sciences Announces Completion of Enrollment in the Company’s Phase 1 Safety and Tolerability Study in Patients with Retinal Disease

Kodiak Sciences Inc. today announced that enrollment of patients in the company’s phase 1 safety and tolerability study has been completed. First patient in was dosed on July 12, 2018 and last patient in was dosed on August 13, 2018.

August 31, 2018
·
2 min read
BioMidwest

Universal Access to Menstrual Care Sweeps Coast to Coast

Recent Laws in N.Y., Calif., and Ill. Signal Sea Change in Movement HOSPECO® Promoted from Beginning

August 31, 2018
·
3 min read